Methode Completes Recapitalization
TM Capital advised Methode Electronics, Inc. (NASDAQ) in completing a $25 million share repurchase which recapitalized Methode into a one-share, one-vote structure
TM Capital advised Methode Electronics, Inc. (NASDAQ) in completing a $25 million share repurchase which recapitalized Methode into a one-share, one-vote structure
TM Capital provided the board of directors of Benihana Inc. with a study of its capitalization and recapitalization alternatives
TM Capital was retained by the Board of Directors of Omega Protein (NYSE) to arrange a senior credit facility
TM Capital advised MCM Capital Group (OTC) regarding the completion of the placement of Participating Convertible Preferred Stock
TM Capital advised PASSUR Aerospace, Inc. in connection with a private placement of common stock
TM Capital advised Diversco, Inc. (NASDAQ) in completing its sale in a management buyout transaction
TM Capital assisted the Board of Directors of Gyrodyne Company of America, Inc. (NASDAQ) in adopting a shareholders rights plan
TM Capital advised Lechters Inc. (NASDAQ) regarding a $65 million equity and debt financing
TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital
TM Capital assisted Hypertherm, Inc. in establishing an Employee Stock Ownership Plan and arranged $40 million of senior debt financing